TOP

A 2023 Calendar for China's Reopening and Recovery

Andy Rothman gives his insight on how China may live with COVID in the months ahead.

In the December 14 issue of Sinology, we explained that China is back on a pragmatic path with the lifting of zero-COVID and property market policies that stalled domestic demand in 2022. While COVID cases are likely to continue to rise in the coming months that is unlikely to disrupt progress towards living with the virus and an economic recovery in the second half of this year. 

China’s leaders continue to take steps designed to remove obstacles to daily life and to support economic growth. Investment Strategist Andy Rothman shares his 2023 monthly outlook on how China’s reopening and economic recovery might play out. This calendar offers his monthly base case, as well as the key risks for China’s reopening.

*As of November 30, 2022, accounts managed by Matthews Asia portfolios held positions in Taiwan Semiconductor Manufacturing Company.

 

IMPORTANT INFORMATION

Investments involve risk. Past performance is no guarantee of future results. Investing in China may involve additional risks, such as social and political instability, market illiquidity, exchange-rate fluctuations, a high level of volatility and limited regulation. This material is provided for informational purposes only and should not be construed as investment advice or an offer to buy, sell, or hold any securities. The information contained herein has been derived from sources believed to be reliable and accurate at the time of compilation, but no representation or warranty (express or implied) is made as to the accuracy or completeness of any of this information. Matthews Asia and its affiliates do not accept any liability for losses either direct or consequential caused by the use of this information. The views and opinions expressed herein are as of the date of publication, are subject to change and may not reflect current views or opinions.